Case 3: 70-Year-Old Former Smoker with Stage IIIB NSCLC with PD-L1 10%
February 27th 2024Dr. Gregory Gan introduces Case 2, involving a 70-year-old former smoker with Stage IIIB NSCLC and a PD-L1 level of 10%, prompting discussion with emphasis on the importance of shared decision-making with the patient and their caregivers.
Advancements in Treating Brain Metastases in HER2+ Breast Cancer
February 23rd 2024Rani Bansal, MD, discusses progressive developments in treating brain metastases in HER2-positive breast cancer, highlighting insights from the TUXEDO and DEBORAH trials, and examines the potential role of T-DXd in managing leptomeningeal disease.